Department of Immunology, Monash University , Clayton, VIC , Australia.
Front Immunol. 2013 Aug 6;4:233. doi: 10.3389/fimmu.2013.00233. eCollection 2013.
In this study, we show that CD25(hi)TNFR2(+) cells can be rapidly generated in vitro from circulating CD4 lymphocytes by polyclonal stimuli anti-CD3 in the presence of anti-CD28. The in vitro induced CD25(hi)TNFR2(+) T cells express a conventional regulatory T cells phenotype FOXP3(+)CTLA4(+)CD127(lo/-), but produce effector and immunoregulatory cytokines including IL-2, IL-10, and IFN-g. These induced CD25(hi)TNFR2(+) T cells do not suppress target cell proliferation, but enhance it instead. Thus the CD25(hi)TNFR2(+) phenotype induced rapidly following CD3/28 cross linking of CD4 T cells identifies cells with maximal proliferative and effector cytokine-producing capability. The in vivo counterpart of this cell population may play an important role in immune response initiation.
在这项研究中,我们表明,通过在抗 CD28 的存在下用多克隆刺激物抗 CD3,循环 CD4 淋巴细胞可以在体外快速产生 CD25(hi)TNFR2(+)细胞。体外诱导的 CD25(hi)TNFR2(+)T 细胞表达常规调节性 T 细胞表型 FOXP3(+)CTLA4(+)CD127(lo/-),但也产生效应和免疫调节细胞因子,包括 IL-2、IL-10 和 IFN-g。这些诱导的 CD25(hi)TNFR2(+)T 细胞不抑制靶细胞增殖,反而增强其增殖。因此,在 CD4 T 细胞的 CD3/28 交联后快速诱导的 CD25(hi)TNFR2(+)表型鉴定出具有最大增殖和效应细胞因子产生能力的细胞。该细胞群的体内对应物可能在免疫反应启动中发挥重要作用。